Neurocrine Biosciences
This role is responsible for executing and maintaining product and disease-specific projects to establish prevalence, burden of disease, or health outcomes from treatment. The position involves collaborating with Global Clinical Development, Medical Affairs, and Brand teams to achieve strategic objectives and contribute to HEOR strategy development. The incumbent will design and implement projects to create evidence that informs commercial strategy, value assessment, and market access.
Headquarters
San Diego, California, United States
Company Size
1001-5000 employees
Founded
1992
Neurocrine Biosciences is a biopharmaceutical company focused on discovering and developing treatments for patients with neurological, psychiatric, endocrine, and immunological disorders. With over 30 years of research, the company works to bring hope to people living with rare diseases and conditions that lack viable treatment options. Neurocrine develops and markets approved medicines while maintaining an active clinical pipeline across multiple therapeutic areas.
Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum
1 day ago
Magnetar Financial LLC Acquires New Holdings in Neurocrine Biosciences, Inc. $NBIX
5 hours ago
Is It Time To Reassess Neurocrine Biosciences (NBIX) After The Recent Share Price Pullback
23 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Neurocrine Biosciences.
4% above the average for this role
Capital Fund Management S.A. Has $17.37 Million Holdings in Neurocrine Biosciences, Inc. $NBIX
7 hours ago
Senior Manager, HEOR - Endocrinology
lifelancer
Health Economics and Outcomes Research (HEOR) Fellowship
Northeastern University
Director, Global HEOR - Oncology
Bristol Myers Squibb
Director, HEOR Therapeutic Area Lead (Acromegaly)
Crinetics Pharmaceuticals
Director, HEOR
lifelancer
US Director, HEOR & RWE
Zealand Pharma